Excedrin's #DebateHeadache was inspired by complaints the brand noticed during the first presidential debate in September.
Cleveland Clinic CEO Toby Cosgrove said at the PRWeek Conference that the pharmaceutical industry has a responsibility to manage drug costs without the government stepping in
As the effectiveness of in-person detailing wanes, how will cloud-based content solutions adapt?
Ad pushes behind brands like Gilead Sciences' hepatitis-C pill Harvoni and Allergan's IBS drug Viberzi buoyed med-surg outlays for the first six months of 2016. Cancer drugs once again were the hottest category.
The firm will handle communications for scar treatment Mederma and is already managing the product launch of cellulite-treatment product Cellfina, the 10-year anniversary of injectable Radiesse, and introducing a product line.
The company promoted Maryellen Royle to global CEO of Tonic Life Communications and Jon Clark to global CEO of Nitrogen.
Physicians are seeking beyond-the-pill services from drugmakers; Novartis debunks misconception that only smokers get lung cancer; pharma's access to docs declines
And why the stories behind thalidomide, Naprosyn, AZT, cardiology stents, and Zaltrap still resonate.
Did you know that Norman Rockwell was a medical illustrator for Merck?
"Standard economic concerns like price elasticity fall out of the equation when people simply have no choices. No one buys an EpiPen for fun," Dr. David Katz writes.
The consultancy includes Double Helix, which was acquired by McCann in 2012.
New Cigna campaign features TV doctors; Walgreens to divest 1,000 stores; senators question Aetna's health exchange exit
They share their insights, secrets, worries, and everything else in between.
Hint: it pays to be an EVP.
Execs say that career prospects are better than ever. Yet data from MM&M's annual Career and Salary Survey reveals a decline in growth.
When the Career and Salary Survey made its debut, in 1987, Eli Lilly's Prozac led the list of mass-market drug launches and AIDS therapy had taken a big step forward with the approval of GlaxoSmithKline's AZT, a year earlier.
"It's easy to 'fill open positions,'" Marchese says. "We've banned that phrase. If you do that, you're just checking boxes on a list."
Physicians are seeking beyond-the-pill services from drugmakers, but few sales reps shares details with docs about these programs, a new report finds.
The current reimbursement climate is more likely to impact how drugmakers order their global product launches than the U.K.'s vote to exit the E.U.
A new bill exempting CME reporting gains physician support; NYT op-ed calls Opdivo DTC ad "misleading;" Valeant to sell non-core assets worth $8 billion
Merck and Allergan reportedly vying to buy Biogen; drugmakers fight California measure capping drug prices; few seniors use the web to look for health info
It's unlikely that pharma will ever achieve the degree of consumer love directed at Amazon and Apple but the shift taking place will open up doors for pharma organizations.
GSK partners with Google to create joint venture; Philips Healthcare launches a health watch; Advent invests in inVentiv Health
Were we trying to celebrate these women for having made hard-won progress in gender parity while also perpetuating a stereotype about them?
McCann Health, the 2016 Lions Health Network of the Year, and Campaign invited top marketers and visionary artists to discuss creativity during this year's Lions Health festival.
Red, a Huntsworth agency, also counted Sanofi as a new client.
Now that it has consolidated its global agency roster, GSK Consumer Healthcare aims to increase digital marketing efforts.
Avanir's success with Nuedexta sparked the attention of several suitors. In 2014 the company reached a deal to be sold to Otsuka Pharmaceutical for around $3.5 billion
Imagine if the agencies pitching us mocha lattes faced these consumer beliefs: The latte will hurt when I drink it. The latte might leave me with a rash or cause me to vomit.
He knew from his fractured childhood that courage in the face of adversity translated into survival and that empathy must be embedded in care and cures.
- Five things for pharma marketers to know: Monday, October 17, 2016
- Guidemark Health merges with three companies to form new agency
- Sermo and Everyday Health partner in advertising-research deal
- Five things for pharma marketers to know: Thursday, October 13, 2016
- Five things for pharma marketers to know: Friday, October 14, 2016
- Merck educates doctors about biosimilars, long before it will sell one in the U.S.
- 4 trends with the potential to change behavior in the patient journey
- 2016 Pharma Report: All the data in one place
- What do physicians think about biosimilars?
- Novartis considers new sales model for experimental cancer therapy
- Trump or Clinton? Either May Lead to Better Mental Healthcare
- Five things for pharma marketers to know: Thursday, October 20, 2016
- Why Excedrin embraced the headache of a contentious election season
- StartUp Health reports more global deals, uptick in pharma investment in digital health
- Five things for pharma marketers to know: Wednesday, October 19, 2016